| Symbol | PAVS |
|---|---|
| Name | PARANOVUS ENTERTAINMENT TECHNOLOGY LTD. |
| Sector | HEALTH CARE |
| Region | Asia |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | NUMBER 11, DONGJIAO EAST ROAD,SHUANGXI, SHUNCHANG, FUJIAN PROVINCE, NANPING, 353200, China |
| Telephone | +86 5997828808 |
| Fax | — |
| — | |
| Website | https://www.pavs.ai |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001751876 |
| Description | Paranovus Entertainment Technology Ltd, formerly Happiness Development Group Ltd, is a company mainly engaged in the production of nutritional products. The Companys main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The Companys main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The Company also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun. Additional info from NASDAQ: |
New Form 424B5 - Paranovus Entertainment Technology Ltd. <b>Filed:</b> 2026-06-16 <b>AccNo:</b> 0001929980-26-000266 <b>Size:</b> 530 KB
Read morePAVS Announces Pricing of a $10 Million Registered Direct Offering of Class A Ordinary Shares and Pre-Funded Warrants
Read morePAVS Announces Pricing of a $10 Million Registered Direct Offering of Class A Ordinary Shares and Pre-Funded Warrants
Read moreNew Form 3 - Paranovus Entertainment Technology Ltd. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001929980-26-000132 <b>Size:</b> 4 KB
Read moreNew Form 424B5 - Paranovus Entertainment Technology Ltd. <b>Filed:</b> 2026-03-25 <b>AccNo:</b> 0001929980-26-000097 <b>Size:</b> 607 KB
Read moreParanovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules
Read more